Avio Smart Market Stack Limited (ASMS)
🎯 Key Takeaways
- ASMS is in a strategic transition phase, shifting focus toward healthcare and digital inclusion while navigating financial constraints and shareholder dilution risks. The company has moved from a high-asset base to a leaner structure with minimal debt, but persistent losses and low margins indicate ongoing operational challenges.
- Revenue declined 65.2% QoQ to ₹12 in Q1FY27.
- ⚠️ Persistent net losses and declining revenue trend despite segment-level profitability, with no clear path to sustainable earnings.
- Market Cap
- ₹184
- P/E Ratio
- 31.8
- P/B Ratio
- 5.39
- ROE
- 17.3%
- ROCE
- 12.8%
- Debt/Equity
- 0.26
- Promoter
- 65.8%
📖 The Story
ASMS is in a strategic transition phase, shifting focus toward healthcare and digital inclusion while navigating financial constraints and shareholder dilution risks. The company has moved from a high-asset base to a leaner structure with minimal debt, but persistent losses and low margins indicate ongoing operational challenges. Management is pursuing inorganic growth via acquisitions and global expansion, though near-term execution risks remain elevated.
📰 What's Happening
In Q3 2026, the board approved unaudited financial results showing ₹122.75 lakhs profit before tax, driven by ₹75.71 lakhs from the Financial Inclusion & Digital Services segment, alongside the acquisition of a 40.96% stake in Shree Naganaarasimha Private Limited and incorporation of Singapore, BIL AgriTech, and BIL HealthTech subsidiaries. The MD was reappointed for three years effective August 12, 2026, and a QIP fundraise was approved pending shareholder and regulatory clearance, with an AGM scheduled for September 3, 2026. Earlier, the incorporation of Avio Healthcare Corporation in the Philippines with 69.99% ownership by BIL Healthtech was announced, signaling a strategic pivot into healthcare services.
Source: Stock Announcements
📊 Quarterly Results (₹ Cr)
| Metric | Jun 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | 9 | 48 | 34 | 12 |
| Operating Profit | -1 | 3 | 2 | 1 |
| OPM % | -9.4% | 5.3% | 6.6% | 5.3% |
| Net Profit | 0 | 2 | 2 | 1 |
| EPS | ₹0.01 | ₹0.08 | ₹0.07 | ₹0.03 |
Revenue has declined sharply from ₹48 lakhs in December 2025 to ₹12 lakhs in June 2026, with operating profit margins remaining volatile and near breakeven levels. Despite a temporary improvement in Q3 2026 (OPM of 6.6%), the company posted a net loss of ₹1 lakh and EPS of ₹0.03, reflecting weak top-line momentum and high fixed cost exposure. The financial trajectory is marked by contraction in core operations, though segment-level profitability in Financial Inclusion & Digital Services offers a potential bright spot underpinning future growth aspirations.
🔮 Management Outlook & What's Next
Management expects growth from the Financial Inclusion & Digital Services segment and has signaled intent to regularize foreign subsidiaries and advance the Ampivo acquisition, pending approvals. The reappointment of the Managing Director for three years underscores leadership continuity, while the QIP and AGM on September 3, 2026, are positioned as key milestones for capital raising and strategic execution. No explicit revenue or margin guidance was provided, but the roadmap hinges on integrating new acquisitions and scaling subsidiaries under regulatory frameworks.
Extracted from official company announcements. Not StockFin.ai's opinion.
🏦 Balance Sheet (₹ Cr)
| Item | Mar 2023 | Mar 2023 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 30 | 34 | 30 | 30 |
| Reserves | 498 | 47 | -2 | 4 |
| Borrowings | 0 | 399 | 0 | 9 |
| Total Liabilities | 750 | 1,743 | 33 | 68 |
| Fixed Assets | 4 | 13 | 0 | 2 |
| Investments | 0 | 0 | 5 | 14 |
| Total Assets | 750 | 1,743 | 33 | 68 |
The balance sheet reflects a drastic reduction in asset base, with total assets declining from ₹750 crores in March 2023 to just ₹68 lakhs by March 2026, indicating aggressive divestment or write-downs. Equity remains flat at ₹30 lakhs, while reserves have swung from ₹498 crores to negative ₹2 lakhs, signaling cumulative losses eroding equity. Borrowings are minimal (₹9 lakhs), suggesting deleveraging, but the fragile capital structure raises concerns about long-term solvency amid ongoing losses.
💰 Cash Flow Statement (₹ Cr)
| Item | Mar 2023 | Mar 2026 |
|---|---|---|
| Operating | -4 | +1 |
| Investing | +1 | -10 |
| Financing | -2 | +8 |
| Net Cash Flow | -6 | -0 |
👥 Shareholding Pattern
| Category | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|
| Promoters | 69.4% | 69.4% | 67.5% | 65.8% |
| FII | 1.7% | 1.7% | 1.7% | 1.5% |
| DII | 0.2% | 0.2% | 0.2% | 0.2% |
| Public | 19.8% | 19.7% | 24.7% | 26.3% |
| # Shareholders | 61,747 | 60,788 | 72,319 | 71,131 |
Promoter holding has remained stable around 65-70%, indicating confidence or limited exit intent, while FII and DII stakes are negligible (under 2% combined), reflecting low institutional interest. The shareholder base has expanded to over 70,000 investors, suggesting retail diffusion, but the lack of significant foreign or domestic institutional accumulation signals limited confidence in near-term recovery. No pledging or selling activity was disclosed in recent quarters.
⚖️ Peer Comparison — IT - Software
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| TCS | 7.37 L Cr | 14.8 | 63.2% | — | 0.00 |
| INFY | 4.08 L Cr | 13.6 | 44.9% | — | 0.00 |
| HCLTECH | 3.32 L Cr | 19.0 | 31.6% | — | 0.00 |
| WIPRO | 1.55 L Cr | 12.4 | 18.1% | — | 0.19 |
| TECHM | 1.49 L Cr | 26.2 | 24.8% | — | 0.00 |
| LTM | 1.19 L Cr | 22.7 | 30.5% | — | 0.00 |
| OFSS | 90,555 | 26.5 | 60.3% | — | 0.00 |
| PERSISTENT | 82,117 | 42.3 | 32.7% | — | 0.00 |
| COFORGE | 76,187 | 35.0 | 25.6% | — | 0.04 |
| MPHASIS | 41,765 | 21.8 | 22.3% | — | 0.17 |
🔗 Peer Stock Analyses
⚠️ Risk Factors
1. Persistent net losses and declining revenue trend despite segment-level profitability, with no clear path to sustainable earnings. 2. Execution risks tied to multiple pending approvals for QIP, Ampivo acquisition, and subsidiary regularization, which could delay strategic progress. 3. High share dilution risk from proposed QIP, potentially pressuring valuation and EPS. 4. Regulatory and integration risks in new healthcare and AgriTech ventures, including foreign investment compliance and operational scalability.
📋 Recent Filings
- 🔴 Announcement2026-09-30ASMS announced a strategic collaboration with Huwel Lifesciences to expand access to Cubo, an ultra-compact RT-PCR testing platform, across India’s pr…
- Announcement2026-09-28ASMS announced that its trading window will close on October 1, 2026, and remain shut until 48 hours after the un-audited quarterly results for Septem…
- 🟡 Board Meeting2026-09-25The company issued a corrigendum to its AGM notice dated September 3, 2026, revising key details of a proposed preferential issue of equity shares to …
- 🔴 Announcement2026-09-24ASMS announced a strategic collaboration with Ampivo Smart Technologies to expand the Agri Kisan Setu digital agriculture platform across its rural ne…
- 🔴 annual report2026-09-04Avio Smart Market Stack Limited (ASMS) announced its 34th AGM on September 30, 2026, via video conference, approving financial statements and reappoin…
- 🟡 Board Meeting2026-09-04ASMS announced the 34th Annual General Meeting will be held on 30 September 2026 via video conference, with book closure from 24 to 30 September 2026 …
- 🟡 Board Meeting2026-09-04The 34th AGM of Avio Smart Market Stack Limited (ASMS) is scheduled for September 30, 2026, via video conference. Shareholders will vote on reappointi…
- 🟡 Board Meeting2026-09-04The 34th AGM of Avio Smart Market Stack Limited (ASMS) is scheduled for September 30, 2026 at 12:00 IST via video conferencing. Shareholders will vote…
- 🔴 annual report2026-09-04Avio Smart Market Stack Limited (ASMS) reported a 159% revenue surge to [amount context mismatch] crores for FY26, driven by strong segment growth, wh…
- 🟡 Board Meeting2026-09-03The Board of Avio Smart Market Stack Limited approved its FY2026 annual report, recommended appointing SVRL & Co. as statutory auditor for five years,…
🧠 Analyst's Read
ASMS is undergoing a high-risk strategic repositioning with limited visibility into near-term profitability, making it a speculative play dependent on execution of its healthcare and digital inclusion ambitions. Investors should monitor the September 2026 AGM outcomes, QIP approval status, and progress in integrating new acquisitions for early signals of turnaround feasibility.
Based on filing content and financial data. Not a recommendation.
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-09-30.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when ASMS files new disclosures
Track ASMS filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track ASMS — FreeFree account · 2 AI queries/day